Journal of Medical Genetics · 2015 · 53 citations · 21 references
This study, examining the origins of vestibular schwannomas in NF2, refutes their origin as being from a single site on the transition zone of the superior division of the vestibular nerve. We hypothesise a relationship between the number of tumour foci, tumour biology and aggressiveness of disease. The development of targeted drug therapies in addition to bevacizumab are therefore essential to improve prognosis and quality of life in patients with NF2 given the shortcomings of surgery and radiation treatments when dealing with the multifocality of the disease.
21
Handbook of clinical neurology
L S Illis · Spinal Cord · 2013 · 915 citations · Full text
Neurobiology Of Disease, Neurological Disorder, Clinical Neurology +6
Bevacizumab for Progressive Vestibular Schwannoma in Neurofibromatosis Type 2
Scott R. Plotkin, Vanessa L. Merker, Chris Halpin et al. · Otology & Neurotology · 2012 · 245 citations · Full text